Biosig announces pricing of public offering of common stock

Westport, ct, june 24, 2022 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”) a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced pricing of its previously-announced best efforts underwritten public offering of up to 4,666,667 shares of its common stock, $0.001 par value per share, at a price to the public of $0.75 per share. the gross proceeds to biosig from this offering are expected to be $3,500,000.25, before deducting the underwriting discount and other estimated offering expenses payable by biosig. the offering is expected to close on june 28, 2022, subject to customary closing conditions.
BSGM Ratings Summary
BSGM Quant Ranking